Rapid Dose Therapeutics Corp. (RDTCF)
USD 0.17
(0.0%)
USD 0.17
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 1.02 Million | 718.29 Thousand | 1.75 Million | 262.8 Thousand | 101.49 Thousand | - |
| Cost of Revenue | 457.01 Thousand | 345.89 Thousand | 407.11 Thousand | 55.35 Thousand | 64.16 Thousand | 156.27 Thousand |
| Gross Profit | 563.4 Thousand | 372.4 Thousand | 1.34 Million | 207.45 Thousand | 37.33 Thousand | -156.27 Thousand |
| Operating Expenses | 4.3 Million | 3.91 Million | 5.64 Million | 2.33 Million | 7.54 Million | 11.48 Million |
| Selling, General and Administrative Expenses | 2.59 Million | 3.18 Million | 4.38 Million | 1.5 Million | 6.78 Million | 11.1 Million |
| Research and Development Expenses | 427.79 Thousand | 92.88 Thousand | 359.29 Thousand | 85.31 Thousand | 272.71 Thousand | 222.35 Thousand |
| Other Expenses | 1.27 Million | - | 8456.00 | -70 Thousand | 90.72 Thousand | - |
| Cost and Expenses | 4.75 Million | 4.26 Million | 6.05 Million | 2.38 Million | 7.6 Million | 11.48 Million |
| Operating Income | -3.73 Million | -3.8 Million | -4.43 Million | -2.26 Million | -7.61 Million | -11.48 Million |
| Interest Expense | 661.45 Thousand | 264.64 Thousand | 133.48 Thousand | 142.56 Thousand | 108.51 Thousand | - |
| Income Tax Expense | - | 264.64 Thousand | 141.93 Thousand | 142.56 Thousand | 199.24 Thousand | -83.37 Thousand |
| Earnings before Tax | -4.3 Million | -3.81 Million | -8.48 Million | -2.29 Million | -7.96 Million | -11.39 Million |
| Net Income | -4.3 Million | -3.81 Million | -8.48 Million | -2.29 Million | -7.96 Million | -11.39 Million |
| Earnings Per Share Basic | -0.04 | -0.04 | -0.08 | -0.03 | -0.10 | -0.18 |
| Earnings Per Share Diluted | -0.04 | -0.04 | -0.08 | -0.03 | -0.10 | -0.18 |
| Weighted Average Shares Outstanding | 104.96 Million | 103.41 Million | 100.21 Million | 77.78 Million | 76.09 Million | 62.74 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.96 Million | 103.41 Million | 100.21 Million | 77.78 Million | 76.09 Million | 62.74 Million |
| Gross Margin | 0.55 | 0.52 | 0.77 | 0.79 | 0.37 | - |
| EBIT Margin | -2.96 | -4.06 | -2.01 | -5.52 | -68.11 | - |
| Profit Margin | -4.22 | -5.30 | -4.84 | -8.74 | -78.47 | - |
| EBITDA | -3.02 Million | -2.91 Million | -3.52 Million | -987.22 Thousand | -7.31 Million | -11.4 Million |
| Earnings Before Tax Margin | -3.66 | -5.30 | -2.53 | -8.64 | -75.01 | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 1.02 Million | 192.65 Thousand | 233.81 Thousand | 353.17 Thousand | 240.78 Thousand | 718.29 Thousand |
| Cost of Revenue | 2.43 Million | 455.32 Thousand | 683.95 Thousand | 664.1 Thousand | 123.18 Thousand | 345.89 Thousand |
| Gross Profit | -1.41 Million | -262.67 Thousand | -450.14 Thousand | -310.93 Thousand | 117.6 Thousand | 372.4 Thousand |
| Operating Expenses | 1.67 Million | 898.27 Thousand | 428.34 Thousand | 245.46 Thousand | 582.77 Thousand | 3.91 Million |
| Selling, General and Administrative Expenses | - | 594.86 Thousand | 327.97 Thousand | 211.4 Thousand | 419.39 Thousand | - |
| Research and Development Expenses | - | 303.41 Thousand | 100.36 Thousand | 1941.00 | 16.86 Thousand | - |
| Other Expenses | - | - | - | -32.12 Thousand | - | - |
| Cost and Expenses | 4.1 Million | 1.35 Million | 1.11 Million | 909.57 Thousand | 705.95 Thousand | 4.26 Million |
| Operating Income | -3.08 Million | -1.16 Million | -878.49 Thousand | -556.4 Thousand | -465.16 Thousand | -3.8 Million |
| Interest Expense | 661.45 Thousand | 304.94 Thousand | 102.59 Thousand | - | 79.63 Thousand | 264.64 Thousand |
| Income Tax Expense | - | -4.00 | 3.00 | 3.00 | 22.08 Thousand | 264.64 Thousand |
| Earnings before Tax | -4.3 Million | -2.05 Million | -981.07 Thousand | -730.68 Thousand | -544.8 Thousand | -3.81 Million |
| Net Income | -4.3 Million | -2.05 Million | -981.07 Thousand | -730.68 Thousand | -566.88 Thousand | -3.81 Million |
| Earnings Per Share Basic | - | -0.02 | -0.01 | -0.01 | -0.01 | - |
| Earnings Per Share Diluted | - | -0.02 | -0.01 | -0.01 | -0.01 | - |
| Weighted Average Shares Outstanding | 104.96 Million | 117.81 Million | 103.88 Million | 103.41 Million | 103.41 Million | 103.41 Million |
| Weighted Average Shares Outstanding (Diluted) | 104.96 Million | 117.81 Million | 103.88 Million | 103.41 Million | 103.41 Million | 103.41 Million |
| Gross Margin | -1.38 | -1.36 | -1.93 | -0.88 | 0.49 | 0.52 |
| EBIT Margin | - | -5.09 | -3.10 | -1.18 | -1.32 | - |
| Profit Margin | -4.22 | -10.66 | -4.20 | -2.07 | -2.35 | -5.30 |
| EBITDA | - | -980.17 Thousand | -725.65 Thousand | -416.21 Thousand | -318.65 Thousand | - |
| Earnings Before Tax Margin | -3.02 | -6.03 | -3.76 | -1.58 | -1.93 | -5.30 |
PESO
AUBANK
AMP
BRZE
TDW-WT
TIXC